CASI PHARMACEUTICALS INC (CASI)
followers
ยท
Follow
Sector: | HEALTH CARE |
Industry: | PHARMACEUTICALS |
SIC: | BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES) |
CEO: | Wei-Wu He |
Employees: | 180 |
Web site: | casipharmaceuticals.com |
9620 MEDICAL CENTER DR, STE 300, ROCKVILLE, MD, 20850
240-864-2600
|
-
Formally known as:
- EntreMed Inc
Are you looking for this stock instead?
Date | Ratio |
---|---|
2010-07-01 | 1:11 |
2022-06-02 | 1:10 |
All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
---|
CASI Pharmaceuticals, Inc. develops and commercializes therapeutics and pharmaceutical products. It offers EVOMELA, an intravenous formulation of melphalan for use as a conditioning treatment prior to stem cell transplantation, and as a palliative treatment for patients with multiple myeloma. The company's product pipeline includes CNCT19, an autologous CD19 CAR-T investigative product for the treatment of patients with B-cell acute lymphoblastic leukemia (B-ALL) and B-NHL)
Please log in first to see chart